期刊
ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE
卷 226, 期 1, 页码 48-55出版社
GEORG THIEME VERLAG KG
DOI: 10.1055/a-1520-5233
关键词
off-label use; pregnancy; lactation; drugs; perinatal centre; recommendations
The study found that similar active ingredients are used in Swiss perinatal centers during both pregnancy and lactation, with fewer guidelines available for the latter.
Background In order to improve the safety of drugs in pregnancy and lactation, it is imperative that data on clinical practice be collected and validated. Methods Data on routinely used medications were requested from 9 Swiss perinatal centres (5 university hospitals for obstetrics and 4 non-university centres). Furthermore, recommendations and guidelines from scientific societies for the fields of application were sought. Results Part II (lactation): For the lactation period, 48 different active substances were each identified by at least 4 centres. The active constituents most frequently cited by the centres were i.v. iron, lorazepam, nifedipine and paracetamol. Only a few guidelines were found that explicitly refer to the breastfeeding period. Therefore, fewer recommendations for use during lactation could be found compared with during pregnancy. Conclusion As with during pregnancy, the same active ingredients are consistently used in Swiss perinatal centres for many different indications during lactation. Most of these active ingredients are labelled with a warning or are even considered to be contraindicated; their use is therefore mainly off-label. Official authorisation for frequently or consistently used active substances is urgently needed. With this study, a first important step towards national harmonisation has been taken.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据